You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Details for New Drug Application (NDA): 050006


✉ Email this page to a colleague

« Back to Dashboard


NDA 050006 describes VIBRAMYCIN, which is a drug marketed by Pfizer and is included in four NDAs. It is available from one supplier. Additional details are available on the VIBRAMYCIN profile page.

The generic ingredient in VIBRAMYCIN is doxycycline calcium. There are twenty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the doxycycline calcium profile page.
Summary for 050006
Tradename:VIBRAMYCIN
Applicant:Pfizer
Ingredient:doxycycline
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 050006
Medical Subject Heading (MeSH) Categories for 050006
Suppliers and Packaging for NDA: 050006
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VIBRAMYCIN doxycycline FOR SUSPENSION;ORAL 050006 NDA Pfizer Laboratories Div Pfizer Inc 0069-0970 0069-0970-65 1 BOTTLE in 1 CARTON (0069-0970-65) / 60 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrengthEQ 25MG BASE/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.